Having trouble viewing this email? View in your browser.

19 February 2019

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


ESCMID Summer School 2019 – Liverpool, UK

We are pleased to announce the opening of registrations for the 18th ESCMID Summer School, to be held in Liverpool from 29 June – 6 July 2019.

The Summer school is a week-long broad update on CM and ID, especially of interest to young professionals in the area. Participants are also invited to present their own work for discussion amongst their peers.

Numbers are limited to only 80 places, so be sure to apply online now!

Attendance grants are available as well, applications close on 16 March 2019.

› Read more

Registration for ECCMID 2019

ECCMID is approaching soon in Amsterdam!

Registrations are available at a reduced rate for ESCMID members on the official website.

Make sure you use our official website to book your hotels to get the best rates.

› Read more

CMI Highlight - Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission

Errico et. Al conducted a prospective cohort study in Italy in order to describe the microbiological aspects of colonization/infection by carbapenemase-producing Enterobacteriaceae (CPE) in donors and recipients of lung and liver transplants and the possible CPE transmission from donors to recipients.
The study showed a low risk of donor-recipient CPE transmission, indicating that donor CPE colonization does not necessarily represent a contraindication for donation unless colonization regards the organ to be transplanted

› Read more

ESCMID endorses the international consensus guidance for the Optimal Use of the Polymyxins

Although the polymyxins became available in the 1950s, interest in them as salvage therapy for multidrug-resistant and extensively drug-resistant gram-negative infections recently reemerged. However, the lack of standard drug development procedures in the 1950s resulted in significant confusion surrounding their current use. To address this confusion and provide practitioners with a guide to the optimal clinical use of the polymyxin antibiotics, a diverse, international panel of 18 experts convened over the past 24 months to reach a consensus on therapeutic recommendations.
At the public consultation phase, ESCMID and EUCAST members provided many helpful comments, and ESCMID finally endorsed the consensus document, which provides the first guidance on appropriate investigation and treatment strategies in this patient population, targeting all stakeholders involved in the clinical use of the polymyxin antibiotics, colistin (polymyxin E) and polymyxin B, for the treatment of bacterial infections in adults.

› Read more

Guideline on management of Candida Infections in critically ill patients open for public consultation

The draft version of the "Guideline on management of Candida" has now entered into the public consultation phase. The guideline is a result of the concerted efforts of experts across Europe.
Those of you wishing to comment on the manuscript may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback. We are happy to receive your feedback and comments on the manuscript until 12th March 2019. Please be aware that your comments and the authors’ responses to the comments will be made available online once the guideline is published.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.